- Home
- FSTR vs IMMP Comparison
FSTR vs IMMP Comparison
Compare FSTR & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- IMMP
- Stock Information
- Founded
- FSTR 1902
- IMMP 1987
- Country
- FSTR United States
- IMMP Australia
- Employees
- FSTR N/A
- IMMP N/A
- Industry
- FSTR Metal Fabrications
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- IMMP Health Care
- Exchange
- FSTR Nasdaq
- IMMP Nasdaq
- Market Cap
- FSTR 285.6M
- IMMP 251.8M
- IPO Year
- FSTR N/A
- IMMP N/A
- Fundamental
- Price
- FSTR $26.74
- IMMP $1.99
- Analyst Decision
- FSTR Hold
- IMMP Buy
- Analyst Count
- FSTR 1
- IMMP 1
- Target Price
- FSTR $25.00
- IMMP $7.00
- AVG Volume (30 Days)
- FSTR 21.7K
- IMMP 193.1K
- Earning Date
- FSTR 11-06-2025
- IMMP 10-10-2025
- Dividend Yield
- FSTR N/A
- IMMP N/A
- EPS Growth
- FSTR 395.33
- IMMP N/A
- EPS
- FSTR 3.32
- IMMP N/A
- Revenue
- FSTR $506,999,000.00
- IMMP $3,306,742.00
- Revenue This Year
- FSTR $3.93
- IMMP $16.82
- Revenue Next Year
- FSTR $4.51
- IMMP N/A
- P/E Ratio
- FSTR $8.01
- IMMP N/A
- Revenue Growth
- FSTR N/A
- IMMP 31.28
- 52 Week Low
- FSTR $17.16
- IMMP $1.32
- 52 Week High
- FSTR $29.78
- IMMP $2.71
- Technical
- Relative Strength Index (RSI)
- FSTR 52.39
- IMMP 56.00
- Support Level
- FSTR $25.94
- IMMP $2.02
- Resistance Level
- FSTR $27.52
- IMMP $2.17
- Average True Range (ATR)
- FSTR 0.72
- IMMP 0.12
- MACD
- FSTR -0.03
- IMMP -0.00
- Stochastic Oscillator
- FSTR 63.38
- IMMP 32.56
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.